published meta-analysis   sensitivity analysis   studies

vaccines in COVID-19 prophylaxis (excluding children) - Summary of results

OutcomeTE95% CInkI2ROBPub. bias confirmed COVID (any severity)detailed resultsAbu-Raddad, 2022 0.53 [0.47; 0.59] Tan, 2022 0.20 [0.14; 0.27] 0.33[0.12; 0.86]Abu-Raddad, 2022, Tan, 2022297%NAnot evaluable symptomatic Covid-19detailed resultsAbu-Raddad, 2022 0.53 [0.47; 0.59] 0.53[0.47; 0.59]Abu-Raddad, 202210%NAnot evaluable0.22.01.0relative treatment effectwww.metaEvidence.org2024-05-10 07:30 +02:00

TE: relative treatment effect (measured by a risk ratio, an odds ratio or an hazard ratio depending on what is reported in the papers); k: number of studies; n: total number of patients; ROB: risk of bias (ROB 2.0); Pub. bias: publication bias; OBS: observational studies; RCT: randomized clinical trials
studied treatment is better when TE > 1; studied treatment is better when TE < 1;

pathologies: 89 - treatments: 551,834,763,922,935,620,1317,1265,824,766,857,1291,1088,1331,1330,1329,1344,1328,1327,979,822,762,805,950,757,761,806,758,826,755,821,1288,1287,1286,760,1284,802,765,1285,759,823,804,1264,764,858,835,1262,1290,1316,1341,1342,1343,825,803 - roots T: 290